Melinta Therapeutics’ Baxdela™ to be Featured in Six Poster Presentations at IDWeek 2016™

World News: . []

NEW ORLEANS Oct 26 2016 GLOBE NEWSWIRE -- Melinta Therapeutics a privately held company exclusively focused on developing novel antibiotics to treat serious bacterial infections announced today that Baxdela delafloxacin an investiga tional,...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Wednesday 26th October 2016

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us